Category: ICH

Vigilare-Biopharma-Insights-TGA-Seeks-Feedback-to-Modernize-Clinical-Trial-Pharmacovigilance-Standards

Vigilare Biopharma Insights: TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Standards

TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Australia’s Therapeutic Goods Administration (TGA) is revising its clinical trial and pharmacovigilance guidelines to align with global benchmarks—a move poised to reshape research and drug safety practices.

Read More

Is Your Clinical Trial Prepared for ICH E6 (R3)? Key Strategies for Compliance and Success

Is your clinical trial ready for ICH E6 (R3)? Discover the key areas to focus on, from risk-based quality management to digital transformation, and ensure compliance with the latest GCP guidelines.

Read More
Quick Enquiry
close slider